— Know what they know.
Not Investment Advice

603998.SS SHH

Hunan Fangsheng Pharmaceutical Co., Ltd.
1W: -1.5% 1M: -3.6% 3M: +10.3% YTD: -16.6% 1Y: -4.2% 3Y: +3.1% 5Y: +94.4%
¥10.36 ($1.54)
+0.10 (+0.97%)
 
SHH · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 46 · ¥4.5B mcap · 271M float · 3.97% daily turnover

📊 Key Metrics

TTM
¥2B
Revenue
+9.9% YoY
¥335M
Net Income
+16.4% YoY
¥432M
Free Cash Flow
+143.2% YoY
76.3%
Gross Margin
26.2%
Op. Margin
22.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE19.6%
ROA10.9%
ROIC18.8%

Valuation

P/E13.7
P/B2.6
EV/EBITDA8.8

Leverage

Debt/Equity0.18
Current Ratio0.95
Interest Cov.36.0x

Quality Scores

Piotroski F9/9
Altman Z3.41
Beneish M-2.95

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms